THE MODERN BIOHEALTH, WITH PERSPECTIVE.
Clinician-led care in Florida

PEPTIDE ATLAS / IMMUNE & GUT / LL-37

EvidenceLimited / mixed topical human evidence
The existing guide’s evidence label applies only to the specific context discussed. Read the sources and limitations; this is not medical approval.
RegulatoryNot FDA-approved
No FDA-approved product for the use discussed. Research interest is not evidence of safe routine treatment.
Corrections & editorial standards

LL-37

Editorial visualization for immune & gut peptide research
THE SIGNAL MAP · IMMUNE & GUT
ALSO KNOWN ASCathelicidin LL-37

An antimicrobial peptide with mixed topical wound-trial results; systemic wellness use remains unestablished.

01CATEGORYImmune & gut
02REGULATORY STATUSNot FDA-approved
03COMMON ROUTETopical in randomized human wound trials; systemic injection is unapproved and benefit is not established
04REVIEW STANDARDProduct, indication and evidence

HOW TO USE THIS PAGE

Read the profile in the order that protects the decision.

  1. 01
    Verify what it is

    Confirm the exact molecule, route, regulatory lane and actual human evidence.

  2. 02
    Read the evidence limits

    Unsupported claims, contraindications and uncertainty come before any protocol.

  3. 03
    Build the monitoring plan

    Define the target, baseline checks, reassessment point and stop rules with a qualified clinician.

IMPORTANT STATUS CHECK

This peptide does not have an FDA-approved product or dose for the claims described here. Research dosing and vendor protocols are not consumer prescribing guidance.

RESEARCH PASSPORT

The five facts to know first.

HUMAN EVIDENCELimited / mixed topical human evidence

Evidence strength for the context described on this page.

REGULATORY LANENot FDA-approved

Status is product-, formulation- and indication-specific.

CLINICAL CONTEXTIndividual evaluation required

Public education does not establish a personal treatment plan.

SOURCE PACK3 direct source links

Plus 0 research searches. A search link is not a cited study or proof of a claim.

TESTED ATHLETESVerify the exact ingredient.

Peptide hormones, growth factors and related substances may be prohibited.

Check Global DRO ↗
Know the review boundary.

Where present, the date above records an editorial content review, not medical approval or a live check of every claim. Follow the official product label and regulator links for current status. This page does not establish availability through Modern Bio.

How we describe evidence →

OVERVIEW

What LL-37 is.

A human cathelicidin involved in innate immunity, antimicrobial defense and inflammation. Endogenous biology does not make systemic supplementation safe.

HOW IT IS THOUGHT TO WORK

Interacts with microbial membranes and multiple host signaling pathways; effects can be antimicrobial, inflammatory, reparative or harmful depending on tissue and context.

EFFECTS & EVIDENCE

What the evidence supports—and what it does not.

SUPPORTED IN CONTEXT
  • Limited, mixed human evidence for topical treatment of venous leg ulcers alongside compression care
  • A larger randomized trial did not show a significant healing benefit in the full study population
  • No established systemic treatment for infection or immune resilience
NOT ESTABLISHED
  • That topical wound studies establish injectable safety or systemic benefit
  • Chronic-infection treatment
  • Biofilm eradication in people
  • General immune enhancement
  • Safe injectable use
RESEARCH UPDATE · November 8, 2026Topical human trials exist, but the overall results are mixed.

A 2014 randomized study of 34 people reported healing signals with topical LL-37. The 2021 phase 2b trial of 148 people, using topical treatment alongside compression care, found no significant healing improvement in the full study population. A post hoc signal in larger ulcers needs confirmation. These results do not establish systemic or injectable benefit, safety, or general infection treatment.

Read the larger randomized topical trial ↗

Evidence grade: Limited / mixed topical human evidence. For an approved drug, “high” refers only to its labeled indication—not every off-label or wellness claim.

CLINICAL CONTEXT

The decision is individual.

Research interest does not establish an approved treatment, a safe personal regimen or reliable product quality. Discuss established alternatives with a qualified clinician.

What is the exact claim?

Identify the outcome, formulation and population actually studied.

What would change the decision?

Review benefits, uncertainty, contraindications and better-studied alternatives.

Who owns follow-up?

A treatment decision needs a responsible clinician, monitoring and a review date.

This public guide does not provide a dosing, injection or self-treatment protocol. Bring the source links and the exact product into a licensed clinical consultation.

MONITORING

What should be tracked.

  • Suspected infection requires organism- and site-specific diagnosis
  • No biomarker makes unapproved systemic use safe

SAFETY

Risks, red flags and reasons to avoid it.

KNOWN OR PLAUSIBLE RISKS
  • FDA cites insufficient safety information
  • Nonclinical findings suggest possible detrimental male reproductive effects
  • May be protumorigenic in some tissues
  • Immunogenicity, impurities and sterility risk
AVOID / ESCALATE
  • Human injection
  • Active cancer
  • Fertility attempts
  • Replacing antibiotics or wound care
Stop and seek careGet urgent medical help for trouble breathing, facial or throat swelling, chest pain, fainting, severe persistent abdominal pain, neurologic changes, severe hypoglycemia, uncontrolled vomiting or a prolonged painful erection.

CLINICIAN VISIT CHECKLIST

Six questions worth bringing with you.

01What exact product is this?

Molecule or analog, salt, concentration, route, manufacturer or compounder, lot and beyond-use date.

02What outcome are we treating?

Name the diagnosis or target, how it will be measured and the realistic time to reassess.

03Why this option?

Ask how it compares with FDA-approved, lower-risk or better-studied alternatives.

04Where did the dose come from?

Label, human trial, specialty guideline or clinic convention—and whether that route and formulation match.

05What is the monitoring plan?

Baseline checks, follow-up measures, interactions, pregnancy considerations and symptoms that mean stop.

06How is quality verified?

Pharmacy license, prescription, identity/potency testing, sterility controls and who handles a product complaint.

Do not improvise reconstitution or convert “units” without the exact concentration. Mixing, storage and beyond-use instructions are product-specific; confirm them with the dispensing pharmacy.

SOURCES & RESEARCH LINKS

Read the record yourself.

We prioritize official prescribing information, FDA regulatory material, registered trials and indexed biomedical literature. Vendor and community dosing protocols are excluded from this public source list. These are supporting reading links, not a completed claim-by-claim citation map. Search links can lead to changing results; their presence does not establish that a particular study supports this profile.

PRODUCTS & TREATMENT ACCESS

There is no product we can responsibly recommend.

AVAILABILITY

Research-chemical and some compounded marketing; not FDA-approved.

MARKET REALITY

Antimicrobial activity in a laboratory does not mean a peptide safely reaches an infection—or improves outcomes—in a person.

NO COMMERCE RECOMMENDATION

Evidence before affiliate revenue.

We do not rank or sell unapproved research peptides. Use the Atlas to discuss safer, evidence-backed alternatives with a qualified clinician.

Explore evidence-backed options →

NEXT STEP

Return to immune & gut peptides.

Explore the category →

YOUR NEXT STEP

Ready for a clinician-led plan?

Clinical review determines the appropriate next step. No treatment is guaranteed.

THE CARE PATH

  1. We order your labs

  2. A licensed clinician reviews results and recommends a plan

  3. Rx sent directly to you when appropriate

Care depends on eligibility and clinical judgment. No prescription is guaranteed. This pathway is not a recommendation for the treatment or test discussed in this guide.

Start your lab reviewExplore free educational tools